BELITE BIO INC - ADR (BLTE) Forecast, Price Target & Analyst Ratings

NASDAQ:BLTE • US07782B1044

Current stock price

152.07 USD
+2.89 (+1.94%)
At close:
152.07 USD
0 (0%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for BELITE BIO INC - ADR (BLTE).

Forecast Snapshot

Consensus Price Target

Price Target
$215.73
+ 41.86% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
May 11, 2026
Period
Q1 / 2026
EPS Estimate
-$0.65
Revenue Estimate
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
84.29%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$215.73
Upside
+ 41.86%
From current price of $152.07 to mean target of $215.73, Based on 14 analyst forecasts
Low
$186.85
Median
$204.51
High
$279.30

Price Target Revisions

1 Month
11.24%
3 Months
14.74%

Price Target Summary

14 Wall Street analysts provided a forecast for the next 12 months for BLTE. The average price target is 215.73 USD. This implies a price increase of 41.86% is expected in the next year compared to the current price of 152.07.
The average price target has been revised upward by 14.74% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

BLTE Current Analyst RatingBLTE Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 2 4 6 8

Analyst Ratings History

BLTE Historical Analyst RatingsBLTE Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6 8 10

Analyst Ratings Consensus

ChartMill Buy Consensus
84.29%
BLTE was analyzed by 14 analysts. The buy percentage consensus is at 84. So analysts seem to be very confident about BLTE.
In the previous month the buy percentage consensus was at a similar level.
BLTE was analyzed by 14 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2026-03-03Cantor FitzgeraldMaintains Overweight -> Overweight
2026-03-03Morgan StanleyMaintains Overweight -> Overweight
2026-03-03HC Wainwright & Co.Maintains Buy -> Buy
2026-01-28HC Wainwright & Co.Reiterate Buy -> Buy
2026-01-26B of A SecuritiesInitiate Buy
2026-01-06Morgan StanleyInitiate Overweight
2025-12-02MizuhoUpgrade Neutral -> Outperform
2025-12-01HC Wainwright & Co.Maintains Buy -> Buy
2025-11-20MizuhoInitiate Neutral
2025-10-31BenchmarkMaintains Buy -> Buy
2025-09-15HC Wainwright & Co.Maintains Buy -> Buy
2025-07-03HC Wainwright & Co.Reiterate Buy -> Buy
2025-05-15Cantor FitzgeraldReiterate Overweight -> Overweight
2025-05-15HC Wainwright & Co.Reiterate Buy -> Buy
2025-03-26BenchmarkReiterate Buy -> Buy
2025-03-18Cantor FitzgeraldReiterate Overweight -> Overweight
2025-03-18HC Wainwright & Co.Reiterate Buy -> Buy
2025-01-21BenchmarkMaintains Buy -> Buy
2024-11-15Maxim GroupMaintains Buy -> Buy
2024-11-13HC Wainwright & Co.Maintains Buy -> Buy
2024-09-12HC Wainwright & Co.Reiterate Buy -> Buy
2024-08-13BenchmarkReiterate Buy -> Buy
2024-08-13HC Wainwright & Co.Maintains Buy -> Buy
2024-06-20Cantor FitzgeraldReiterate Overweight
2024-06-13HC Wainwright & Co.Reiterate Buy -> Buy

Next Earnings Forecast Details

Next Earnings Details

Release Date
May 11, 2026
Period
Q1 / 2026
EPS Estimate
-$0.65
Revenue Estimate
Revenue Q2Q
N/A
EPS Q2Q
-44.42%
Number of Analysts
10

Next Earnings Revisions

Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
0.00%
EPS (3 Months)
-3.72%

Next Earnings Summary

BLTE is expected to report earnings on 5/11/2026. The consensus EPS estimate for the next earnings is -0.65 USD and the consensus revenue estimate is 0 USD.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2026 - 2033

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
BLTE revenue by date.BLTE revenue by date.
N/AN/AN/A
363.39%		N/A
218.26%		N/A
108.23%		N/A
41.02%		N/A
33.86%		N/A
26.59%		N/A
10.41%
EBITDA
YoY % growth
BLTE ebitda by date.BLTE ebitda by date.
-5.72M-9.77M
-70.80%		-12.76M
-30.60%		-31.529M
-147.09%		-39.828M
-26.32%		N/A
40.14%		N/A
-54.29%		N/A
649.06%		N/A
179.55%		N/A
62.02%		N/A
35.89%		N/A
50.84%		N/A
37.33%		N/A
3.03%
EBIT
YoY % growth
BLTE ebit by date.BLTE ebit by date.
-5.74M-9.8M
-70.73%		-12.82M
-30.82%		-31.668M
-147.02%		-39.996M
-26.30%		N/A
-98.53%		N/A
-14.06%		N/A
21.49%		N/A
304.06%		N/A
343.88%		N/A
47.27%		N/A
32.64%		N/A
30.68%		N/A
10.64%
Operating Margin
BLTE operating margin by date.BLTE operating margin by date.
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
EPS
YoY % growth
BLTE eps by date.BLTE eps by date.
N/AN/AN/A-1.24
-85.60%		-1.18
4.84%		-2.30
-94.92%		N/A
45.26%		N/A
-54.34%		N/A
311.55%		N/A
337.88%		N/A
32.58%		N/A
40.90%		N/A
32.47%		N/A
8.09%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27
EPS
Q2Q % growth		-0.65
-44.42%		-0.68
-36.97%		-0.71
-8.95%		-0.08
87.93%		-0.42
35.65%		-0.13
80.64%		0.09
112.96%		0.37
534.47%
Revenue
Q2Q % growth		30.6M16.513M32.977M48.36M64.459M
110.65%
EBITDA
Q2Q % growth		-26.336M-27.356M-28.601MN/AN/AN/AN/AN/A
EBIT
Q2Q % growth		-26.87M
-73.17%		-27.98M
-59.01%		-28.865M
-196.35%		-5.023M
75.86%		-16.354M
39.14%		-5.256M
81.21%		3.783M
113.11%		14.608M
390.84%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

BLTE Yearly Revenue VS EstimatesBLTE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2026 2027 2028 2029 2030 2031 2032 2033 500M 1B 1.5B 2B
BLTE Yearly EPS VS EstimatesBLTE Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 10 20 30 40

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
55.87%
EPS Next 5 Year
65.39%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
93.09%
EBIT Next 5 Year
91.20%
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

BELITE BIO INC - ADR / BLTE Forecast FAQ

What is the price target for BLTE stock?

14 analysts have analysed BLTE and the average price target is 215.73 USD. This implies a price increase of 41.86% is expected in the next year compared to the current price of 152.07.

What is the next earnings date for BLTE stock?

BELITE BIO INC - ADR (BLTE) will report earnings on 2026-05-11.

What are the consensus estimates for BELITE BIO INC - ADR (BLTE) next earnings?

The consensus EPS estimate for the next earnings of BELITE BIO INC - ADR (BLTE) is -0.65 USD and the consensus revenue estimate is 0 USD.